Mihály Hajós

A Novel Positive Allosteric Modulator of the α7 Neuronal Nicotinic Acetylcholine Receptor:<i>In Vitro</i>and<i>In Vivo</i>Characterization

Raymond S Hurst, Mihály Hajós, M. Raggenbass et al. · Journal of Neuroscience · 2005 · 444 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Interaction between a selective 5‐HT_1Areceptor antagonist and an SSRI in vivo: effects on 5‐HT cell firing and extracellular 5‐HT

Sarah E. Gartside, Valerie Umbers, Mihály Hajós et al. · British Journal of Pharmacology · 1995 · 313 citations · Full text

Medicine, Neuroscience, Pharmacology +17

An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat

Mihály Hajós, Carl D. Richards, Andrea Székely et al. · Neuroscience · 1998 · 303 citations

Medicine, Neurobiology, Neuroscience +15

Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia

C J Schmidt, Douglas S. Chapin, J. Cianfrogna et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 284 citations

Medicine, Neuroscience, Pharmacology +13

The Selective α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 [N-[(3 R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide Hydrochloride] Enhances GABAergic Synaptic Activity in Brain Slices and Restores Auditory Gating Deficits in Anesthetized Rats

Mihály Hajós, Raymond S Hurst, William E. Hoffmann et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 223 citations

Life Sciences, Neuroscience, Pharmacology +14